VCA
BMY icon

Verdence Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.4M Sell
30,239
-30,642
-50% -$1.42M 0.1% 207
2025
Q1
$3.71M Sell
60,881
-5,871
-9% -$358K 0.28% 90
2024
Q4
$3.78M Sell
66,752
-12,042
-15% -$681K 0.3% 83
2024
Q3
$4.08M Buy
78,794
+4,958
+7% +$257K 0.32% 72
2024
Q2
$3.07M Buy
73,836
+12,599
+21% +$523K 0.27% 93
2024
Q1
$3.32M Buy
61,237
+18,564
+44% +$1.01M 0.3% 88
2023
Q4
$2.19M Buy
42,673
+1,433
+3% +$73.5K 0.21% 121
2023
Q3
$2.39M Sell
41,240
-6,979
-14% -$405K 0.26% 103
2023
Q2
$3.08M Buy
48,219
+227
+0.5% +$14.5K 0.36% 71
2023
Q1
$3.33M Sell
47,992
-478
-1% -$33.1K 0.4% 64
2022
Q4
$3.49M Sell
48,470
-3,490
-7% -$251K 0.43% 52
2022
Q3
$3.69M Sell
51,960
-5,959
-10% -$424K 0.51% 47
2022
Q2
$4.46M Sell
57,919
-10,790
-16% -$831K 0.58% 40
2022
Q1
$5.02M Sell
68,709
-45,133
-40% -$3.3M 0.57% 41
2021
Q4
$7.1M Buy
113,842
+6,023
+6% +$376K 0.84% 24
2021
Q3
$6.38M Buy
107,819
+13,947
+15% +$825K 0.84% 25
2021
Q2
$6.27M Buy
93,872
+24,460
+35% +$1.63M 0.87% 22
2021
Q1
$4.38M Sell
69,412
-348
-0.5% -$22K 0.74% 30
2020
Q4
$4.33M Buy
69,760
+715
+1% +$44.3K 0.82% 22
2020
Q3
$4.16M Buy
69,045
+52,445
+316% +$3.16M 0.95% 19
2020
Q2
$976K Buy
16,600
+4,754
+40% +$280K 0.24% 108
2020
Q1
$660K Sell
11,846
-84
-0.7% -$4.68K 0.2% 130
2019
Q4
$766K Buy
11,930
+1,882
+19% +$121K 0.19% 127
2019
Q3
$510K Buy
10,048
+1,174
+13% +$59.6K 0.14% 168
2019
Q2
$402K Buy
8,874
+132
+2% +$5.98K 0.12% 193
2019
Q1
$417K Buy
8,742
+115
+1% +$5.49K 0.11% 177
2018
Q4
$448K Buy
8,627
+49
+0.6% +$2.55K 0.13% 152
2018
Q3
$532K Sell
8,578
-1,169
-12% -$72.5K 0.13% 159
2018
Q2
$539K Sell
9,747
-1,049
-10% -$58K 0.13% 162
2018
Q1
$683K Sell
10,796
-1,407
-12% -$89K 0.16% 142
2017
Q4
$748K Buy
+12,203
New +$748K 0.18% 107